Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1660020/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849731449626820608 |
|---|---|
| author | Xiangyu Xu Zheng Ma |
| author_facet | Xiangyu Xu Zheng Ma |
| author_sort | Xiangyu Xu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-8f6a36c2cc0f4b26b10c798f5577bcbb |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-8f6a36c2cc0f4b26b10c798f5577bcbb2025-08-20T03:08:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16600201660020Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature reviewXiangyu XuZheng Mahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1660020/fullnon-small cell lung cancer (NSCLC)brain metastasisprogrammed cell death ligand 1tumor mutational burden (TMB)pathological complete response (PCR)circulating tumor DNA (ctDNA) |
| spellingShingle | Xiangyu Xu Zheng Ma Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review Frontiers in Immunology non-small cell lung cancer (NSCLC) brain metastasis programmed cell death ligand 1 tumor mutational burden (TMB) pathological complete response (PCR) circulating tumor DNA (ctDNA) |
| title | Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review |
| title_full | Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review |
| title_fullStr | Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review |
| title_full_unstemmed | Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review |
| title_short | Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review |
| title_sort | correction a stage iv lung squamous cell cancer patient with brain metastases high pd l1 tmb achieves pcr and long term survival after immune chemotherapy and radical surgery a case report and literature review |
| topic | non-small cell lung cancer (NSCLC) brain metastasis programmed cell death ligand 1 tumor mutational burden (TMB) pathological complete response (PCR) circulating tumor DNA (ctDNA) |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1660020/full |
| work_keys_str_mv | AT xiangyuxu correctionastageivlungsquamouscellcancerpatientwithbrainmetastaseshighpdl1tmbachievespcrandlongtermsurvivalafterimmunechemotherapyandradicalsurgeryacasereportandliteraturereview AT zhengma correctionastageivlungsquamouscellcancerpatientwithbrainmetastaseshighpdl1tmbachievespcrandlongtermsurvivalafterimmunechemotherapyandradicalsurgeryacasereportandliteraturereview |